In order to test whether transcription of BAT1 and the homologous gene DDXL was altered in AD, mRNA levels of both BAT1 and DDXL were examined in brain frontal cortex tissue of AD and control cases. This evidence concerns the gene DDX39A and Alzheimer disease.